doxazosin mesylate
Generic: doxazosin mesylate
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
doxazosin mesylate
Generic Name
doxazosin mesylate
Labeler
mylan pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
doxazosin mesylate 8 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59762-1391
Product ID
59762-1391_af51b645-f7da-4e48-84b3-59bcc153937b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA019668
Listing Expiration
2026-12-31
Marketing Start
2025-05-09
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
597621391
Hyphenated Format
59762-1391
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
doxazosin mesylate (source: ndc)
Generic Name
doxazosin mesylate (source: ndc)
Application Number
NDA019668 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 mg/1
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING Doxazosin is available as tablets for oral administration. Each tablet contains Doxazosin mesylate equivalent to 1 mg (white), 2 mg (white), 4 mg (white) or 8 mg (white) of doxazosin as the free base. NDC and Pack Size Strength Description NDC 59762-1388-7 (Bottle of 100) 1 mg White, round tablets with “CN1” on one side and “VLE” on the other side. NDC 59762-1389-7 (Bottle of 100) 2 mg White, oblong tablets with score and “CN 2” on one side and “VLE” on the other side. NDC 59762-1390-7 (Bottle of 100) 4 mg White, rhombus shaped tablets with break score and “CN 4” on one side and VLE on the other side. NDC 59762-1391-7 (Bottle of 100) 8 mg White, capsule shaped tablets with break score and “CN 8” on one side and “VLE” on the other side. Recommended Storage: Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
- PRINCIPAL DISPLAY PANEL – 1 mg NDC 59762-1388-7 100 Tablets doxazosin tablets 1 mg* Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 1 mg doxazosin as a free base. Made in Germany Distributed by: Greenstone LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. RGST1388A Doxazosin Tablets Bottle Labels 1 mg
- PRINCIPAL DISPLAY PANEL – 2 mg NDC 59762-1389-7 100 Tablets doxazosin tablets 2 mg* Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 2 mg doxazosin as a free base. Made in Germany Distributed by: Greenstone LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. RGST1389A Doxazosin Tablets Bottle Labels 2 mg
- PRINCIPAL DISPLAY PANEL – 4 mg NDC 59762-1390-7 100 Tablets doxazosin tablets 4 mg* Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin as a free base. Made in Germany Distributed by: Greenstone LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. RGST1390A Doxazosin Tablets Bottle Labels 4 mg
- PRINCIPAL DISPLAY PANEL – 8 mg NDC 59762-1391-7 100 Tablets doxazosin tablets 8 mg* Rx only Store at 25°C (77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Recommended Dosage See prescribing information. *Each tablet contains doxazosin mesylate equivalent to 8 mg doxazosin as a free base. Made in Germany Distributed by: Greenstone LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. RGST1391A Doxazosin Tablets Bottle Labels 8 mg
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "af51b645-f7da-4e48-84b3-59bcc153937b", "openfda": {"upc": ["0359762138972", "0359762139078", "0359762138873", "0359762139177"], "unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["2e524986-7903-416f-b2b8-d27295103e75"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Doxazosin mesylate", "product_id": "59762-1391_af51b645-f7da-4e48-84b3-59bcc153937b", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "59762-1391", "generic_name": "doxazosin mesylate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin mesylate", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "8 mg/1"}], "application_number": "NDA019668", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20250509", "listing_expiration_date": "20261231"}